Harnessing AI and Proteomics for Glioblastoma

Dr. Andra V. Krauze is a Physician Early Investigator, Radiation Oncologist at NCI NIH, with a focus on leveraging and optimizing computational approaches for identification and implementation of clinically relevant oncologic biomarkers. She is experienced as a clinician and researcher, including research on computational approaches to large-scale data originating from the British Columbia Cancer Registry across several tumor sites.

Dr. DeAunne Denmark is the Senior Director of Translational Medicine and Clinical Development at SomaLogic. She is a clinical translational physician-scientist with specialization in molecular and genomic medicine, and with recent focus on precision approaches to complex chronic illness and rare, undiagnosed, and neuroimmune diseases. For over ten years prior to SomaLogic, she served in multiple roles across healthcare, academia, industry, early-stage ventures, and non-profits to develop and directly apply emerging precision technologies toward transforming clinical research and patient care. At SomaLogic, Dr. Denmark works closely with life sciences and academic clients as well as internal R&D teams to further develop high-value proteomics applications for translational and clinical sciences. She completed her MD and PhD in Behavioral Genetics and Neuroscience through the Medical Scientist Training Program at Oregon Health & Sciences University supported by an NIH fellowship for work focused on integrated molecular and behavioral systems approaches to understanding complex traits and genetic vulnerability to neuropsychiatric disease.